Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1146-1152

  Zahn, Ralf ^a   Hamm, Christian W ^b   Schneider, Steffen ^c   Zeymer, Uwe ^c   Richardt, Gert ^d   Kelm, Malte ^e   Levenson, Benny ^f   Bonzel, Tassilo ^g   Tebbe, Ulrich ^h   Sabin, Georg ⁱ   Nienaber, Christoph A ^j   Senges, Jochen ^c  

^a KLINIKUM NÜRNBERG   (Germany)

^b KERCKHOFF HEART CENTER   (Germany)

^c Herzzentrum   (Germany)

^d Segeberger Kliniken   (Germany)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f Kardiologische Praxis   (Germany)

^g KLINIKUM FULDA   (Germany)

^h KLINIKUM LIPPE DETMOLD   (Germany)

ⁱ ELISABETH KRANKENHAUS ESSEN   (Germany)

^j ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY STENT; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; RISK; RISK FACTOR; ST SEGMENT ELEVATION;

ACUTE DISEASE; AGED; CORONARY DISEASE; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SIROLIMUS; STENTS; STROKE VOLUME; SYNDROME;

EID: 33845297692     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.07.011     Document Type: Article

References (33)

1. Kastrati A., Elezi S., Dirschinger J., et al. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 83 (1999) 1617-1622
2. Kastrati A., Schömig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
3. Bauters C., Hubert E., Prat A., et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 31 (1998) 1291-1298
4. Serruys P.W., Kay I.P., Disco C., et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol 34 (1999) 1067-1074
5. de Feyter P.J., Kay P., Disco C., et al. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 100 (1999) 1777-1783
6. Mercado N., Boersma E., Wijns W., et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 38 (2001) 645-652
7. Sousa J.E., Costa M.A., Abizaid A., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
8. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107 (2003) 24-27
9. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis. The first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
10. Tanabe K., Serruys P.W., Grube E., et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107 (2003) 559-564
11. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
12. Grube E., Silber S., Hauptmann K.E., et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
13. Hong M.K., Mintz G.S., Lee C.W., et al. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
14. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
15. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
16. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
17. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
18. Schofer J., Schlüter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
19. Lemos P.A., Hoye A., Goedhart D., et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
20. Zahn R., Hamm C.W., Schneider S., et al. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry). Am J Cardiol 95 (2005) 1302-1308
21. Espinola-Klein C., Rupprecht H.J., Erbel R., et al. Impact of restenosis 10 years after coronary angioplasty. Eur Heart J 19 (1998) 1047-1053
22. Rupprecht H.J., Espinola-Klein C., Erbel R., et al. Impact of routine angiographic follow-up after angioplasty. Am Heart J 136 (1998) 613-619
23. Schühlen H., Kastrati A., Dirschinger J., et al. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98 (1998) 104-111
24. Schühlen H., Kastrati A., Mehilli J., et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 147 (2004) 317-322
25. Zahn R., Hamm C.W., Zeymer U., et al. "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry. Z Kardiol 93 (2004) 287-294
26. Zahn R., Hamm C.W., Zeymer U., et al. Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective Multicenter German Cypher trade mark Registry. Herz 29 (2004) 181-186
27. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
28. Volpi A., De V.C., Franzosi M.G., et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 database. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 88 (1993) 416-429
29. Peterson E.D., Shaw L.J., and Califf R.M. Risk stratification after myocardial infarction. Ann Intern Med 126 (1997) 561-582
30. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 (2001) 1117-1124
31. Lemos P.A., Serruys P.W., van Domburg R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "Real World." The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Circulation 109 (2004) 190-195
32. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
33. McFadden E.P., Stabile E., Regar E., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521